Medical Properties Trust (MPW) Stock Forecast, Price Target & Predictions
MPW Stock Forecast
Medical Properties Trust stock forecast is as follows: an average price target of $11.33 (represents a 81.57% upside from MPW’s last price of $6.24) and a rating consensus of 'Hold', based on 11 wall street analysts offering a 1-year stock forecast.
MPW Price Target
The average price target for Medical Properties Trust (MPW) is $11.33 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $4.00. This represents a potential 81.57% upside from MPW's last price of $6.24.
MPW Analyst Ratings
According to 11 Wall Street analysts, Medical Properties Trust's rating consensus is 'Hold'. The analyst rating breakdown for MPW stock is 0 'Strong Buy' (0.00%), 4 'Buy' (36.36%), 6 'Hold' (54.55%), 1 'Sell' (9.09%), and 0 'Strong Sell' (0.00%).
Medical Properties Trust Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 13, 2024 | Michael Lewis | Truist Financial | $6.00 | $5.60 | 7.14% | -3.85% |
| Sep 13, 2024 | David Toti | Colliers Securities | $6.50 | $5.60 | 16.07% | 4.17% |
| Sep 12, 2024 | Vikram Malhotra | Mizuho Securities | $7.00 | $5.65 | 23.85% | 12.18% |
| Aug 02, 2024 | Dori Kesten | Wells Fargo | $7.50 | $4.63 | 61.99% | 20.19% |
| Aug 02, 2024 | Michael Lewis | Truist Financial | $8.00 | $4.63 | 72.79% | 28.21% |
| Jul 01, 2024 | Nate Crossett | BNP Paribas | $4.00 | $4.09 | -2.20% | -35.90% |
| May 29, 2024 | Michael Lewis | Truist Financial | $5.00 | $4.98 | 0.40% | -19.87% |
| May 13, 2024 | Michael Carroll | RBC Capital | $5.00 | $5.58 | -10.39% | -19.87% |
| Apr 17, 2024 | Omotayo Okusanya | Deutsche Bank | $5.00 | $4.62 | 8.23% | -19.87% |
| Apr 08, 2024 | Michael Lewis | Truist Financial | $4.50 | $4.05 | 11.11% | -27.88% |
The latest Medical Properties Trust stock forecast, released on Sep 13, 2024 by Michael Lewis from Truist Financial, set a price target of $6.00, which represents a 7.14% increase from the stock price at the time of the forecast ($5.60), and a -3.85% decrease from MPW last price ($6.24).
Medical Properties Trust Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 3 | 6 | 10 |
| Avg Price Target | $6.50 | $6.50 | $5.85 |
| Last Closing Price | $6.24 | $6.24 | $6.24 |
| Upside/Downside | 4.17% | 4.17% | -6.25% |
In the current month, the average price target of Medical Properties Trust stock is $6.50, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 4.17% increase as opposed to Medical Properties Trust's last price of $6.24. This month's average price target is down 0.00% compared to last quarter, and up 11.11% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | Colliers Securities | - | Buy | Upgrade |
| Aug 02, 2024 | Wells Fargo | Underweight | Underweight | Hold |
| Aug 02, 2024 | HSBC | - | Hold | Initialise |
| Jul 01, 2024 | Exane BNP Paribas | Outperform | Neutral | Downgrade |
| May 13, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
| Apr 17, 2024 | Deutsche Bank | Underweight | Hold | Upgrade |
| Mar 01, 2024 | Exane BNP Paribas | - | Outperform | Upgrade |
| Feb 05, 2024 | Wells Fargo | Underweight | Underweight | Hold |
| Dec 01, 2023 | Raymond James | Strong Buy | Underperform | Downgrade |
| Dec 01, 2023 | BMO Capital | Outperform | Outperform | Hold |
Medical Properties Trust's last stock rating was published by Colliers Securities on Sep 13, 2024. The company Upgrade its MPW rating from "null" to "Buy".
Medical Properties Trust Financial Forecast
Medical Properties Trust Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $-122.38M | $306.58M | $337.39M | $350.21M | $380.49M | $352.34M | - | $409.80M | $409.33M | $390.78M | $381.79M | $362.76M | $333.81M | $329.46M | $291.84M | $294.13M | $256.44M | $224.76M |
| Avg Forecast | $282.67M | $283.37M | $285.87M | $278.93M | $273.77M | $270.96M | $269.88M | $261.78M | $262.30M | $263.77M | $259.53M | $270.14M | $300.77M | $333.98M | $344.44M | $347.51M | $364.71M | $383.57M | $394.25M | $399.52M | $395.11M | $379.68M | $360.58M | $338.50M | $327.09M | $308.72M | $296.23M | $298.33M | $263.39M | $220.43M |
| High Forecast | $294.10M | $294.83M | $297.43M | $290.21M | $284.84M | $281.92M | $280.79M | $272.37M | $272.91M | $288.86M | $270.03M | $281.06M | $401.39M | $349.86M | $358.36M | $361.56M | $379.46M | $399.08M | $394.25M | $453.41M | $448.41M | $430.90M | $409.22M | $384.16M | $371.21M | $350.36M | $336.20M | $338.58M | $298.92M | $250.17M |
| Low Forecast | $272.10M | $272.77M | $275.18M | $268.50M | $263.53M | $260.83M | $259.79M | $251.99M | $252.49M | $241.98M | $249.82M | $260.03M | $87.15M | $320.27M | $331.55M | $334.51M | $351.07M | $369.22M | $394.25M | $328.43M | $324.80M | $312.12M | $296.42M | $278.26M | $268.88M | $253.78M | $243.52M | $245.25M | $216.52M | $181.21M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 8 | 5 | 5 | 10 | 7 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.41% | 0.92% | 0.98% | 1.01% | 1.04% | 0.92% | - | 1.03% | 1.04% | 1.03% | 1.06% | 1.07% | 1.02% | 1.07% | 0.99% | 0.99% | 0.97% | 1.02% |
Medical Properties Trust's average Quarter revenue forecast for Mar 24 based on 2 analysts is $270.14M, with a low forecast of $260.03M, and a high forecast of $281.06M. MPW's average Quarter revenue forecast represents a -320.73% decrease compared to the company's last Quarter revenue of $-122.38M (Dec 23).
Medical Properties Trust EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 8 | 5 | 5 | 10 | 7 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-582.31M | $315.23M | $173.71M | $390.85M | $612.88M | $341.75M | - | $368.19M | $299.01M | $270.18M | $243.81M | $250.75M | $191.26M | $301.95M | $259.06M | $229.73M | $246.31M | $195.20M |
| Avg Forecast | $68.64M | $68.81M | $69.41M | $67.73M | $66.48M | $65.79M | $65.53M | $63.56M | $63.69M | $64.05M | $63.02M | $65.59M | $73.03M | $81.10M | $83.64M | $84.38M | $88.56M | $286.58M | $95.73M | $323.72M | $270.07M | $260.53M | $243.81M | $231.46M | $240.85M | $250.14M | $240.03M | $241.73M | $214.18M | $204.49M |
| High Forecast | $71.41M | $71.59M | $72.22M | $70.47M | $69.16M | $68.45M | $68.18M | $66.14M | $66.27M | $70.14M | $65.57M | $68.25M | $97.46M | $84.95M | $87.02M | $87.79M | $92.14M | $343.90M | $95.73M | $367.39M | $324.09M | $312.64M | $292.58M | $277.75M | $289.02M | $283.89M | $272.41M | $274.34M | $257.02M | $245.39M |
| Low Forecast | $66.07M | $66.23M | $66.82M | $65.20M | $63.99M | $63.33M | $63.08M | $61.19M | $61.31M | $58.76M | $60.66M | $63.14M | $21.16M | $77.77M | $80.51M | $81.22M | $85.25M | $229.27M | $95.73M | $266.12M | $216.06M | $208.43M | $195.05M | $185.17M | $192.68M | $205.63M | $197.32M | $198.72M | $171.35M | $163.59M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -7.97% | 3.89% | 2.08% | 4.63% | 6.92% | 1.19% | - | 1.14% | 1.11% | 1.04% | 1.00% | 1.08% | 0.79% | 1.21% | 1.08% | 0.95% | 1.15% | 0.95% |
4 analysts predict MPW's average Quarter EBITDA for Dec 23 to be $73.03M, with a high of $97.46M and a low of $21.16M. This is -76.83% lower than Medical Properties Trust's previous annual EBITDA (Sep 23) of $315.23M.
Medical Properties Trust Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 8 | 5 | 5 | 10 | 7 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-655.62M | $116.71M | $-338.96M | $32.79M | $-140.21M | $221.79M | - | $631.68M | $206.84M | $171.14M | $114.56M | $163.78M | $109.88M | $131.11M | $109.47M | $80.99M | $129.64M | $89.79M |
| Avg Forecast | $18.00M | $6.00M | $-6.00M | $6.00M | $33.00M | $27.00M | $21.00M | $24.00M | $39.61M | $48.83M | $26.68M | $1.06B | $87.58M | $114.88M | $130.66M | $963.82M | $164.47M | $181.53M | $177.38M | $876.20M | $186.55M | $165.02M | $114.56M | $151.18M | $138.37M | $136.15M | $130.52M | $106.74M | $112.73M | $94.06M |
| High Forecast | $18.95M | $6.32M | $-5.71M | $6.32M | $34.74M | $28.42M | $22.11M | $25.26M | $41.69M | $53.27M | $28.09M | $1.27B | $103.80M | $120.93M | $137.53M | $1.16B | $173.12M | $217.83M | $177.38M | $1.05B | $223.86M | $198.03M | $137.48M | $181.42M | $166.05M | $163.38M | $156.62M | $128.08M | $135.27M | $112.87M |
| Low Forecast | $17.13M | $5.71M | $-6.32M | $5.71M | $31.40M | $25.69M | $19.98M | $22.84M | $37.68M | $39.95M | $25.39M | $848.16M | $77.85M | $102.79M | $124.30M | $771.06M | $156.47M | $145.22M | $177.38M | $700.96M | $149.24M | $132.02M | $91.65M | $120.95M | $110.70M | $108.92M | $104.42M | $85.39M | $90.18M | $75.25M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -7.49% | 1.02% | -2.59% | 0.03% | -0.85% | 1.22% | - | 0.72% | 1.11% | 1.04% | 1.00% | 1.08% | 0.79% | 0.96% | 0.84% | 0.76% | 1.15% | 0.95% |
Medical Properties Trust's average Quarter net income forecast for Dec 23 is $87.58M, with a range of $77.85M to $103.80M. MPW's average Quarter net income forecast represents a -24.96% decrease compared to the company's last Quarter net income of $116.71M (Sep 23).
Medical Properties Trust SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 8 | 5 | 5 | 10 | 7 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $30.15M | $38.11M | $35.60M | $41.72M | $42.89M | $37.32M | - | $41.42M | $38.33M | $36.69M | $34.55M | $36.07M | $106.74M | $101.38M | $93.48M | $94.31M | $71.55M | $64.12M |
| Avg Forecast | $32.99M | $33.07M | $33.36M | $32.56M | $31.95M | $31.63M | $31.50M | $30.55M | $30.61M | $30.79M | $30.29M | $69.53M | $35.10M | $38.98M | $40.20M | $63.21M | $42.57M | $38.92M | $46.01M | $57.46M | $34.62M | $35.38M | $34.55M | $33.30M | $134.41M | $105.28M | $111.46M | $124.28M | $62.22M | $67.17M |
| High Forecast | $34.33M | $34.41M | $34.71M | $33.87M | $33.24M | $32.90M | $32.77M | $31.79M | $31.85M | $33.71M | $31.52M | $83.43M | $46.85M | $40.83M | $41.83M | $75.85M | $44.29M | $46.71M | $46.01M | $68.95M | $41.54M | $42.46M | $41.45M | $39.96M | $161.29M | $126.34M | $133.75M | $149.14M | $74.67M | $80.61M |
| Low Forecast | $31.76M | $31.84M | $32.12M | $31.34M | $30.76M | $30.44M | $30.32M | $29.41M | $29.47M | $28.24M | $29.16M | $55.62M | $10.17M | $37.38M | $38.70M | $50.56M | $40.97M | $31.14M | $46.01M | $45.97M | $27.69M | $28.31M | $27.64M | $26.64M | $107.53M | $84.23M | $89.17M | $99.43M | $49.78M | $53.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.86% | 0.98% | 0.89% | 0.66% | 1.01% | 0.96% | - | 0.72% | 1.11% | 1.04% | 1.00% | 1.08% | 0.79% | 0.96% | 0.84% | 0.76% | 1.15% | 0.95% |
Medical Properties Trust's average Quarter SG&A projection for Mar 24 is $69.53M, based on 2 Wall Street analysts, with a range of $55.62M to $83.43M. The forecast indicates a 130.60% rise compared to MPW last annual SG&A of $30.15M (Dec 23).
Medical Properties Trust EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 8 | 5 | 5 | 10 | 7 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-1.09 | $0.19 | $-0.57 | $0.06 | $-0.23 | $0.37 | - | $1.05 | $0.35 | $0.29 | $0.19 | $0.28 | $0.20 | $0.25 | $0.21 | $0.15 | $0.26 | $0.20 |
| Avg Forecast | $0.03 | $0.01 | $-0.01 | $0.01 | $0.06 | $0.04 | $0.04 | $0.04 | $0.07 | $0.08 | $0.04 | $0.09 | $0.15 | $0.19 | $0.22 | $0.22 | $0.27 | $0.30 | $0.30 | $0.31 | $0.31 | $0.28 | $0.29 | $0.26 | $0.27 | $0.26 | $0.26 | $0.28 | $0.23 | $0.21 |
| High Forecast | $0.03 | $0.01 | $-0.01 | $0.01 | $0.06 | $0.05 | $0.04 | $0.04 | $0.07 | $0.09 | $0.05 | $0.09 | $0.17 | $0.20 | $0.23 | $0.23 | $0.29 | $0.32 | $0.30 | $0.36 | $0.37 | $0.33 | $0.34 | $0.31 | $0.31 | $0.30 | $0.30 | $0.33 | $0.27 | $0.25 |
| Low Forecast | $0.03 | $0.01 | $-0.01 | $0.01 | $0.05 | $0.04 | $0.03 | $0.04 | $0.06 | $0.07 | $0.04 | $0.09 | $0.13 | $0.17 | $0.21 | $0.21 | $0.26 | $0.29 | $0.30 | $0.23 | $0.24 | $0.22 | $0.22 | $0.20 | $0.20 | $0.20 | $0.20 | $0.22 | $0.18 | $0.16 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -7.47% | 0.99% | -2.62% | 0.25% | -0.84% | 1.23% | - | 3.44% | 1.13% | 1.03% | 0.67% | 1.07% | 0.75% | 0.97% | 0.82% | 0.53% | 1.12% | 0.95% |
According to 4 Wall Street analysts, Medical Properties Trust's projected average Quarter EPS for Dec 23 is $0.15, with a low estimate of $0.13 and a high estimate of $0.17. This represents a -23.18% decrease compared to MPW previous annual EPS of $0.19 (Sep 23).
Medical Properties Trust Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MPW | Medical Properties Trust | $6.24 | $11.33 | 81.57% | Hold |
| CHCT | Community Healthcare Trust | $17.44 | $22.00 | 26.15% | Buy |
| HR | Healthcare Realty Trust | $18.19 | $19.00 | 4.45% | Buy |
| LTC | LTC Properties | $37.27 | $38.67 | 3.76% | Hold |
| VTR | Ventas | $64.43 | $61.34 | -4.80% | Buy |
| SBRA | Sabra Health Care REIT | $18.93 | $17.29 | -8.66% | Hold |
| OHI | Omega Healthcare Investors | $40.55 | $35.73 | -11.89% | Buy |
| CTRE | CareTrust REIT | $31.00 | $25.50 | -17.74% | Buy |
| NHI | National Health Investors | $84.74 | $67.25 | -20.64% | Hold |
MPW Forecast FAQ
Is Medical Properties Trust a good buy?
No, according to 11 Wall Street analysts, Medical Properties Trust (MPW) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 36.36% of MPW's total ratings.
What is MPW's price target?
Medical Properties Trust (MPW) average price target is $11.33 with a range of $4 to $27, implying a 81.57% from its last price of $6.24. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Medical Properties Trust stock go up soon?
According to Wall Street analysts' prediction for MPW stock, the company can go up by 81.57% (from the last price of $6.24 to the average price target of $11.33), up by 332.69% based on the highest stock price target, and down by -35.90% based on the lowest stock price target.
Can Medical Properties Trust stock reach $9?
MPW's average twelve months analyst stock price target of $11.33 supports the claim that Medical Properties Trust can reach $9 in the near future.
What is Medical Properties Trust's current price target trend?
3 Wall Street analysts forecast a $6.5 price target for Medical Properties Trust (MPW) this month, up 4.17% from its last price of $6.24. Compared to the last 3 and 12 months, the average price target increased by 4.17% and decreased by -6.25%, respectively.
What are Medical Properties Trust's analysts' financial forecasts?
Medical Properties Trust's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.08B (high $1.12B, low $1.04B), average EBITDA is $261.37M (high $271.94M, low $251.59M), average net income is $105.01M (high $110.53M, low $99.9M), average SG&A $125.63M (high $130.71M, low $120.93M), and average EPS is $0.175 (high $0.184, low $0.166). MPW's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.13B (high $1.18B, low $1.09B), average EBITDA is $274.59M (high $285.69M, low $264.32M), average net income is $24M (high $25.87M, low $22.23M), average SG&A $131.98M (high $137.32M, low $127.05M), and average EPS is $0.04 (high $0.0431, low $0.037).
Did the MPW's actual financial results beat the analysts' financial forecasts?
Based on Medical Properties Trust's last annual report (Dec 2023), the company's revenue was $871.8M, which missed the average analysts forecast of $1.33B by -34.29%. Apple's EBITDA was $-83.411M, missing the average prediction of $322.14M by -125.89%. The company's net income was $-817M, missing the average estimation of $1.3B by -163.03%. Apple's SG&A was $145.59M, missing the average forecast of $177.49M by -17.97%. Lastly, the company's EPS was $-1.37, missing the average prediction of $0.778 by -276.19%. In terms of the last quarterly report (Dec 2023), Medical Properties Trust's revenue was $-122M, missing the average analysts' forecast of $300.77M by -140.69%. The company's EBITDA was $-582M, missing the average prediction of $73.03M by -897.33%. Medical Properties Trust's net income was $-656M, missing the average estimation of $87.58M by -848.61%. The company's SG&A was $30.15M, missing the average forecast of $35.1M by -14.11%. Lastly, the company's EPS was $-1.09, missing the average prediction of $0.146 by -846.83%